Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21

Go back to Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21
GALECTIN (NASDAQ: GALT) Delayed: 3.44 -0.09 (2.55%)
Previous Close $3.53    52 Week High $3.05 
Open $3.50    52 Week Low $0.49 
Day High $3.55    P/E N/A 
Day Low $3.20    EPS $-1.32 
Volume 388,207